Bibliography
- Carter J, Beillin J, Morton A, et al. Usability, participant acceptance and safety of SoloStar in a 3-month observational survey in everyday clinical practice. J Diabetes Sci Technol 2007;1(Suppl 1):A21
- De Luise M, Beillin J, Morton A, et al. Influence of diabetes type and previous experience of pen devices on acceptance and usability of a new pen: an observational survey on SoloStar use. J Diabetes Sci Technol 2007;1(Suppl 1):A30
- Schwartz SL, Vlajnic A. Validation of the SoloStar insulin pen. J Diabetes Sci Technol 2007;1(Suppl 1):A159
- Roberts A, Thornley S. Health care professional-reported usability of SoloStar in a 3-month observational survey in everyday clinical practice. J Diabetes Sci Technol 2007;1(Suppl 1):A151
- Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv 2007;4(2):165-74
- Owens DR. Study to compare the injection force required for the following insulin pen devices: Lilly disposable pen, Novo FlexPen, and SoloStar. J Diabetes Sci Technol 2007;1(Suppl 1):A134
- IMS Health. IMS Midas(TM) June 2007, Quarterly insulin sales volume in units. 2007
- Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28(10):1712-25
- International Organization for Standardization. Pen-injectors for medical use – Part 1: Pen-injectors – Requirements and test methods (ISO 11608-1:2000). Geneva, Switzerland: International Organization for Standardization; December 2000
- Aljahlan M, Lee KC, Toth E. Limited joint mobility in diabetes. Postgrad Med 1999;105(2):99-101, 5-6
- Casanova JE, Casanova JS, Young MJ. Hand function in patients with diabetes mellitus. South Med J 1991;84(9):1111-3
- Rosenbloom AL. Limitation of finger joint mobility in diabetes mellitus. J Diabetes Complications 1989;3(2):77-87
- Savas S, Koroglu BK, Koyuncuoglu HR, et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77(1):77-83
- Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12(3):128-32
- Starkman HS, Gleason RE, Rand LI, et al. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis 1986;45(2):130-5
- Gehrs KM, Anderson DH, Johnson LV, et al. Age-related macular degeneration–emerging pathogenetic and therapeutic concepts. Ann Med 2006;38(7):450-71
- Whiteside MM, Wallhagen MI, Pettengill E. Sensory impairment in older adults: part 2: Vision loss. Am J Nurs 2006;106(11):52-61; quiz 61-2
- Aylward GW. Progressive changes in diabetics and their management. Eye 2005;19(10):1115-8
- Wong T, Mitchell P. The eye in hypertension. Lancet 2007;369(9559):425-35
- Wong TY, Klein R, Amirul Islam FM, et al. Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study. Am J Ophthalmol 2007;143(6):970-6
- Fong DS, Barton FB, Bresnick GH. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15. Am J Ophthalmol 1999;128(5):612-7
- de Jong PT. Age-related macular degeneration. N Engl J Med 2006;355(14):1474-85
- McIntyre DA. Colour blindness: causes and effects. Chester: Dalton Publishing; 2002
- Austin F, Cox G. Lantus SoloStar and Apidra SoloStar pen colors contributes to the differentiation by users with normal vision and by users with impaired color vision. J Diabetes Sci Technol 2007;1(Suppl 1):A4
- Haak T, Edelman S, Walter C, et al. Comparison of usability and patient preference for the new disposable insulin device SoloStar versus Flexpen, Lilly disposable pen, and a prototype pen: an open-label study. Clin Ther 2007;29(4):650-60
- Fox C, McKinnon C, Wall A, et al. Ability to handle, and patient preference for, insulin delivery devices in visually impaired patients with type 2 diabetes. Pract Diab Int 2002;19:104-7
- Petzinger RA. Diabetes aids and products for people with visual or physical impairment. Diabetes Educ 1992;18(2):121-38
- Schreiber S, Ferlinz K, Donaubauer B. The Reliability and Usability of SoloSTAR® (SOL) Disposable Pen in Clinical Practice in Germany. Presented at the CDA/CSEM Professional Conference and Annual Meeting, Montreal, Quebec, October 15–18, 2008. Abstract 88
- Pawaskar MD, Camacho FT, Anderson RT, et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther 2007;29:1294-305